摘要
6-[124I]iodo-2-(4′-N,N-dimethylamino)-phenylimidazo[1,2 -a]pyridine ([124I]IMPY) was synthesized and characterized as a positron-emitting probe to identify Alzheimer's disease in transgenic mouse models. A significant reduction in radioactivity retention in the hippocampus and frontal cortex by co-incubation with nonradioactive IMPY was observed. Highly specific retention of radioactivity in beta-amyloid-rich regions of brain sections was also noted. This study demonstrated that [124I]IMPY was a promising probe for the mouse model and may be useful for positron emission tomography to image beta-amyloid plaques in the human brain.
原文 | 英語 |
---|---|
頁(從 - 到) | 1397-1400 |
頁數 | 4 |
期刊 | Applied Radiation and Isotopes |
卷 | 67 |
發行號 | 7-8 |
DOIs | |
出版狀態 | 已發佈 - 7月 1 2009 |
ASJC Scopus subject areas
- 輻射